Hologic, Inc.

NasdaqGS:HOLX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🩺 Medical Instruments

Location

United States

Market Cap

USD 15.08 B

Share Price

USD 67.82

Avg Daily Volume

2,616,725

Change (1 day)

0.82%

Change (1 year)

-16.63%

Change (YTD)

-5.92%

Hologic, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 28, 2025: USD 1.01 B

Hologic, Inc. EBITDA is USD 1.01 B for the Trailing 12 Months (TTM) ending June 28, 2025, a -17.27% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Hologic, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 29, 2024 was USD 1.22 B, a 11.64% change year over year.
Hologic, Inc. EBITDA for the Trailing 12 Months (TTM) ending July 01, 2023 was USD 1.09 B, a -54.38% change year over year.
Hologic, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 25, 2022 was USD 2.39 B, a -21.22% change year over year.
Hologic, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 26, 2021 was USD 3.03 B, a 221.90% change year over year.